Metraipolis › archive › dc_c708f6e1abc2

PKM2-Mediated Glycolytic Reprogramming in Thyroid Cancer: Mechanistic Insights and Therapeutic Potential — Europe PMC PMID:42280115

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42280115
DOI
10.3390/molecules31111811
License (as archived)
solo-consultazione
Archived
2026-11-01T08:03:38.833Z
SHA-256 of the archived text
f945153f448b4e1b129b1a481e00c1b804af75df5cd9aa1afc8a83ecc2a8aa42
Stable URL of this page
https://metraipolis.com/documento/dc_c708f6e1abc2

How to cite

PKM2-Mediated Glycolytic Reprogramming in Thyroid Cancer: Mechanistic Insights and Therapeutic Potential — Europe PMC PMID:42280115 — Europe PMC (en), https://europepmc.org/article/MED/42280115 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c708f6e1abc2 (Metraipolis archive dc_c708f6e1abc2, sha256 f945153f448b4e1b129b1a481e00c1b804af75df5cd9aa1afc8a83ecc2a8aa42)
BibTeX
@misc{dcc708f6e1abc2,
  title = {PKM2-Mediated Glycolytic Reprogramming in Thyroid Cancer: Mechanistic Insights and Therapeutic Potential — Europe PMC PMID:42280115},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42280115},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c708f6e1abc2; sha256 f945153f448b4e1b129b1a481e00c1b804af75df5cd9aa1afc8a83ecc2a8aa42},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42280115. Agents can read the archived copy with the MCP tool read_document.